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L-domain-containing proteins from animal retroviruses play a critical role in the recruitment of the host cell endocytic machinery that is
required for retroviruses budding. We recently demonstrated that phosphorylation of the p6gag protein containing the L-domain of the human
immunodeficiency virus type 1 regulates viral assembly and budding. Here, we investigated whether or not the L-domain-containing protein from
another human retrovirus, namely the matrix protein of the human T-cell leukemia virus type 1, that contains the canonical PTAP and PPPY L-
domain motifs, shares similar functional properties. We found that MA is phosphorylated at several sites. We identified one phosphorylated amino
acid in the HTLV-1 MA protein as being S105, located in the close vicinity to the L-domain sequence. S105 phosphorylation was found to be
mediated by the cellular kinase ERK-2 that is incorporated within HTLV-1 virus particles in an active form. Mutation of the ERK-2 target S105
residue into an alanine was found to decrease viral release and budding efficiency of the HTLV-1ACH molecular clone from transfected cells. Our
data thus support the postulate that phosphorylation of retroviral L-domain proteins is a common feature to retroviruses that participates in the
regulation of viral budding.
© 2006 Elsevier Inc. All rights reserved.Keywords: HTLV-1; Phosphorylation; L-domain; ERK-2; BuddingIntroduction
L-domain motifs consist of conserved sequences that are
critical for viral particle assembly and efficient release of
assembled virions from the cell membrane. Comparative
analysis of L-domains from several retroviruses has shown
that despite marked divergences in their sequences, they
accomplish the same late budding function and are function-
ally interchangeable with respect to their effect on particleAbbreviations:MA, matrix; L-domain, late domain; PKA, AMPc-dependent
protein kinase; MAPK, mitogen-activated protein kinase; ERK, extra cellular
signal-regulated kinase; GST, glutathion S transferase; HRP, horseradish
peroxidase.
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doi:10.1016/j.virol.2006.02.043release (Parent et al., 1995). This function relies on the
presence of a conserved PPPY motif located between the
matrix and capsid proteins of Rous sarcoma virus, murine
leukemia virus (MLV) and Mason–Pfizer monkey virus
(Craven et al., 1999; Parent et al., 1995; Yasuda and Hunter,
1998; Yuan et al., 2000). For lentiviruses, the L-domain
function is fulfilled either by the presence of a PTAP
sequence in the human immunodeficiency virus (HIV-1) p6gag
domain at the C-terminal end of the Gag polyprotein or by an
YPDL sequence located within the C-terminus of the p9
protein of equine infectious anemia virus (EIAV) (Garnier et
al., 1998; Huang et al., 1995; Puffer et al., 1997). A particular
organization was reported for the human T cell leukemia virus
type 1 (HTLV-1) L-domain which consists in a combination
of PTAP and PPPY sequences (PPPYEPTAP) that are located
at the C-terminal end of the matrix (MA) protein (Le Blanc
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proteins that belong to the class E vacuolar protein sorting
factors (Martin-Serrano et al., 2003). The conserved consensus
motifs, PTAP, PPPY and YPXL have been shown to regulate
viral budding by recruiting the proteins Tsg101, Nedd4 and
AP2 or AIP, respectively (for review, see Demirov and Freed,
2004). For HTLV-1, recent studies showed that both PTAP and
PPPY motifs are required for viral release (Blot et al., 2004;
Bouamr et al., 2003; Wang et al., 2004). Furthermore, the
successive interaction of the PPPY sequence with the proline-
recognition WW domain of the Nedd4 E3 ubiquitin ligase and
of the PTAP motif with Tsg101 was demonstrated to
contribute to the efficient release of HTLV-1 particles (Blot
et al., 2004).
Retroviral L-domain-containing proteins are subject to
post-translational modifications. During the past few years,
direct interactions have been reported between ubiquitin and a
number of L-domain-containing proteins, including HIV-1
p6gag, MLV p12 and EIAV p9 proteins. These interactions
occurred in the vicinity of the L domain (Ott et al., 1998,
2002). Furthermore, the use of proteasome inhibitors which
deplete free ubiquitin cellular pools by inducing the
accumulation of poly-ubiquitin complexes, suggested that
ubiquitination plays a direct role in viral release (Patnaik et al.,
2000; Schubert et al., 2000). Besides ubiquitination, which has
been related to the budding capacity of many viruses (Vogt,
2000), L-domain-containing proteins are phosphorylated
independently of the nature of the L-domain sequence. Indeed,
the murine leukemia virus p12 protein (Yueh and Goff, 2003;
Sen et al., 1977) and the pp16 protein of Mason–Pfizer
monkey virus (Bradac and Hunter, 1984) are phosphoproteins.
Recently, we and others reported that HIV-1 p6gag is
phosphorylated (Hémonnot et al., 2004; Muller et al., 2002),
and we proposed that the virus-associated ERK-2 protein
kinase is required in such phosphorylations. To date, the
relationships linking phosphorylations to a functional role of
the target viral protein still remain to be elucidated. The
present study was designed to extend the analysis of L-domain
protein phosphorylation by investigating the status of the
HTLV-1 MA protein. Phosphorylation assays carried out using
lysate of purified viral particles as a substrate indicate that the
HTLV-1 MA protein is phosphorylated by host cell encoded
virus-associated kinases. The nature of kinases packaged
within HTLV-1 particles was investigated and the presence of
the mitogen-activated protein kinase (MAPK) ERK-2 was
evidenced in preparations of purified virions. In addition, by
using in vitro assay, we demonstrated that ERK-2 directly
contributes to MA phosphorylation. By analyzing point
mutations of the C-terminal moiety of the MA protein, we
found that ERK-2 targets a single serine residue, belonging to
a highly conserved canonical MAPK consensus motif, located
at position 105 in MA, close to the L-domain. Substitution of
S105 residue into an alanine, in the context of the HTLV-1ACH
molecular clone, was found to decrease viral release and to
induce the accumulation of early arrested budding structures at
the host cell plasma membrane with little free virus as
observed using electron microscopy analysis. Altogether, ourdata show that the HTLV-1 MA protein may be phosphory-
lated by cellular ERK-2 kinase and indicate that phosphory-
lation of L-domain-containing proteins may be a common
post-translational modification required for appropriate retro-
viruses budding.
Results
HTLV-1 MA protein is phosphorylated by virus-associated
kinases
Phosphorylation of HTLV-1 encoded proteins was inves-
tigated. To this end, HTLV-1 particles were purified from
supernatant of HUT102 chronically infected cells by
ultracentrifugation on an OptiPrep velocity gradient under
conditions described in Materials and methods. This method
allows recovering virions devoid from contaminating nonviral
extracellular proteins (Dettenhofer and Yu, 1999). HTLV-1
particles were then lysed and incubated in the presence of [γ-
32P]ATP and appropriate kinase buffer. Phosphorylated
products were then separated by SDS-PAGE and revealed
by autoradiography. As shown in Fig. 1A, multiple
phosphorylated proteins were detected, with a major
phosphorylated product with an apparent molecular weight
of 19 kDa. To ascertain that the proteins detected are from
viral origin and devoid from contaminating cellular proteins,
an extract was prepared under the same experimental
procedures, from supernatant of CEM cells, another T-cell
line that is negative for HTLV-1. With the exception of a
single high molecular weight product detected from CEM
preparation, no contaminant protein was observed from this
control sample, supporting the claim that the phosphorylation
pattern obtained from virion lysate reflects viral proteins
phosphorylation. The nature of the major phosphorylated
virus-associated protein was next investigated by probing the
membrane with antibodies specific for HTLV-1 proteins. As
observed in Fig. 1B, the 19 kDa phosphorylated protein
associated with purified HTLV-1 particles was detected using
an anti-MA serum. Phosphorylation of MA protein by host
cell kinase was ascertained by immunoprecipitation experi-
ments. As shown in Fig. 1C, matrix protein immunopreci-
pitated from virus lysate incubated in the presence of [γ-32P]
ATP was found to be phosphorylated. In addition, phosphor-
ylation was also observed when GST-MA fusion protein was
incubated in the presence of a total extract obtained from
activated CEM lymphocytes and radioactive [γ-32P]ATP (Fig.
1D). Altogether, our results indicate that the phosphorylated 19
kDa is the HTLV-1 MA protein and that MA is phosphorylated
by a host cell protein kinase(s) packaged within HTLV-1
particles.
ERK-2 protein kinase is incorporated within HTLV-1 virions
The nature of HTLV-1 virion-associated kinases was then
investigated in Western blotting experiments. Lysates of
highly purified HTLV-1 particles were analyzed by immuno-
blot experiments using antibodies raised to various host cell
Fig. 1. Analysis of HTLV-1 proteins phosphorylation. (A) Lysate of HTLV-1 virions purified from culture supernatant of the HTLV-1 positive HUT102 cell line was
incubated in the presence of [γ-32P]ATP in kinase buffer. Phosphorylated products were revealed by autoradiography. Extract prepared from supernatant of HTLV-1
negative CEM cells using the same experimental procedure is shown as a control. (B) Matrix (MA) protein was identified by probing the membrane with an anti-MA
polyclonal serum. The position of the phosphorylated MA is indicated by an arrow and relative molecular mass (Mr) markers are shown on the left. (C) Virus lysate
subjected to phosphorylation assay was immunoprecipitated by using anti-MA mAbs or irrelevant mAbs (Ir). Immunoprecipitated proteins were detected by
autoradiography (left panel) or with anti-MA mAbs (right panel). (D) Matrix protein fused to GSTwas incubated in the presence of total extract from activated CEM
cells in the presence of [γ-32P]ATP. Phosphorylated products were separated on SDS-PAGE and revealed by autoradiography (left panel). Amount of GST-fused
proteins in each line was controlled using anti-GST mAbs (right panel).
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evidenced in purified HTLV-1 virions. A similar approach
showed that the same preparation also contained the 40 kDa
catalytic subunit of AMPc-dependent protein kinase A (C-
PKA) and the p38 mitogen-activated protein kinase
(p38MAPK). No signal was detected when a sample preparedFig. 2. Detection of virus-associated ERK-2, C-PKA and p38MAPK by
immunoblotting. Highly purified HTLV-1 particles prepared from supernatant
of HTLV-1-positive HUT102 cells were analyzed for ERK-2, C-PKA and
p38MAPK content in immunoblotting experiments. For each experiment, an
extract prepared from supernatant of HTLV-1 negative CEM cells is shown as a
control. Protein expression was controlled from total cell extracts prepared from
CEM and HUT102 cells and expression of HTLV-1 proteins is controlled using
an anti-MA serum.from the supernatant of HTLV-1 negative human T cells was
incubated with anti-ERK-2 or anti-p38MAPK mAbs or with C-
PKA anti-serum, indicating that the method used for
purification of viral particles avoids the presence of
contaminating cellular microvesicles. Thus, it appears that
several host-cell protein kinases are associated with the
purified HTLV-1 particles. Interestingly, similar results were
obtained when lysate of subtilisin-treated particles was
subjected to immunoblotting experiments (data not shown),
suggesting that ERK-2, C-PKA and p38MAPK are not bound
to the virus particle envelope but embedded within HTLV-1
virions. The activation level of virus-associated ERK-2 kinase
was next questioned by using BioPlex technology combined
with anti-phospho-ERK2 antibodies. The presence of phos-
pho-ERK-2 was quantified according to a standardization
curve established using increasing concentrations of phospho-
peptides. As shown in Table 1, we found that activated/
phosphorylated forms of ERK-2 are detected specifically from
HTLV-1 particle lysate as compared to extract prepared fromTable 1
Detection of activated ERK-2 incorporated within HTLV-1 virions by BioPlex
assay
Sample Relative fluorescence intensity
Negative 0
Control peptide 12,066
Uninfected supernatant 690
HUT 102 supernatant 2227
HTLV-1 virions purified from supernatant of chronically infected HUT102 cells
were assayed by using Bioplex technology. Sample prepared from supernatant
of CEM uninfected cells and a control peptide mimicking phospho-ERK-2 are
used as negative and positive controls, respectively.
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show that at least three host cell kinases, including activated
ERK-2, p38MAPK and C-PKA, are associated to HTLV-1 viral
particles.
The HTLV-1 MA protein is phosphorylated in vitro by ERK-2
The contribution of virus-associated kinases in MA phos-
phorylation was next investigated in in vitro phosphorylation
assays. Fusion proteins containing the sequences encoding the
complete matrix, capsid (CA) or nucleocapsid (NC) in frame
with the GST protein were generated (described in Fig. 3A) and
incubated in the presence of recombinant activated ERK-2
kinase (phosphorylated both on threonine-183 and tyrosine-185
residues) and [γ-32P]ATP, in an appropriate reaction buffer.
Phosphorylated proteins were separated on SDS-PAGE,
transferred onto PVDF membrane and revealed by autoradiog-
raphy. As shown in Fig. 3B, GST-MA protein was phosphor-
ylated when incubated in the presence of activated ERK-2. The
NC protein fused to GST, despite greatly instable, was found to
be phosphorylated at a weak level. In contrast, no phosphor-
ylation was observed using GST-CA as a substrate. GST alone
and GST fused to Elk, a natural substrate of ERK-2, are shown
as negative and positive controls, respectively. For each sample,
the amount of GST-fusion proteins loaded in each lane wasFig. 3. In vitro phosphorylation analysis of GST-fused HTLV-1 structural prot
phosphorylation experiments. L-domain motifs are boxed. The positions of flanking a
Immobilized GST viral fusion proteins were incubated in the presence of activated ER
autoradiography (upper panel). GSTand GST-Elk proteins are shown as controls. Lev
membrane with HRP conjugated anti-GST mAbs (lower panel).checked by Western blotting of the membrane with anti-GST
mAbs (Fig. 3B; lower panel). To define the region of MA
targeted by ERK-2, a GST-fused truncated MA protein (MA-
DomL) containing the MA region surrounding the L-domain
tandem (amino acids 87 to 130) was used in in vitro kinase
experiments. As shown in Fig. 3B, the truncated MA-DomL
was found phosphorylated at a similar level than that observed
for GST-MA protein, indicating the presence of an ERK-2
phosphorylation site between amino acid residues 87 and 130 of
MA. Altogether, our results indicate that the MA protein of
HTLV-1 is phosphorylated by ERK-2. At least one of the
residue(s) targeted is located in the C-terminal domain of the
protein, nearby the L-domain motif.
ERK-2 phosphorylates S105 residue of the HTLV-1 MA protein
In order to predict which amino acid residue(s) of the
MA protein is/are phosphorylated by ERK-2, the presence of
ERK-2 consensus motifs was scanned in the total amino acid
sequence using the NetPhos algorithm (http://www.cbs.dtu.
dk/services/NetPhos/). Two canonical ERK-2 motifs, repre-
sented by the [S/T]-P minimal sequence, both with high
probability score, were identified at positions 10 and 105 of the
MA protein encoded by the HTLV-1ACH molecular clone (Fig.
4A). Although sequence heterogeneity between HTLV-1eins. (A) Schematic representation of GST-fused proteins used in in vitro
mino acids are indicated. GST localization is illustrated by the symbol (•). (B)
K-2 and [γ-32P]ATP in kinase buffer. Phosphorylated proteins were revealed by
el of GST-fused proteins loaded in each lane was ascertained by incubation of the
Fig. 4. Characterization of HTLV-1 MA protein residues phosphorylated by ERK-2. (A) Amino acid sequence of the HTLV-1 MA protein. Putative consensus
phosphorylation sites for ERK-2 are underlined. Amino acids belonging to the L-domain tandem motif are shadowed in grey. (B) GST-fused wild type MA (GST-MA)
or truncated MA (GST-MA-DomL) or the corresponding serine-to-alanine 105 mutant proteins MAS/A and MA-DomLS/A, were incubated in the presence of activated
ERK-2 and [γ-32P]ATP in kinase buffer. After separation on SDS-PAGE, protein phosphorylation was revealed by autoradiography (upper panel). GST and GST-Elk
proteins are shown as controls. Levels of GST-fused proteins loaded in each lane were determined by immunoblotting with HRP conjugated anti-GST mAbs (lower
panel).
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can be identified. Of HTLV-1 sequences available from the
EMBL database, most showed sequence homology with the
HTLV-1ACH strain used in this study, with conservation of both
ERK-2 consensus motifs. The respective contribution of S10
and S105 residues in ERK-2-dependent phosphorylation of the
MA protein was then evaluated in vitro. To this end, S105
residue of the GST-MA and GST-MA-DomL fusion proteins
was replaced by an alanine by site-directed mutagenesis.
Mutated GST-fused proteins, respectively referred as GST-
MAS/A and GST-MA-DomLS/A, were then incubated in the
presence of radioactive [γ-32P]ATP and recombinant activated
ERK-2. As presented in Fig. 4B, phosphorylation of the GST-
MA-DomL fusion protein was found to be abolished when the
S105 residue was mutated into an alanine, strongly suggesting
that the S105 residue appears to be the unique serine residue
targeted by ERK-2 between amino acids 87 and 130 of the MA
protein. In contrast, the phosphorylation level of GST-MAS/A
was found to be approximately 50% lower (as indicated by
densitometry scanning of the autoradiography-data not shown)
as compared to the phosphorylation level of the wild type MA
sequence expressed on GST-MA fusion protein. These data
indicate that residue(s) distinct of S105 accounts for the viral
MA global phosphorylation by ERK-2. Several residues are thus
targeted by ERK-2 within the HTLV-1 MA amino acid
sequence. Among these, S105 is the only residue phosphory-
lated by ERK-2 in the C-terminal domain of the MA protein,
near the L-domain motif.Contribution of ERK-2-dependent phosphorylation of HTLV-1
MA in viral release
We next investigated the functional relevance of matrix S105
phosphorylation by ERK-2 in virus life cycle. Toward this end,
an HTLV-1 molecular clone with residue S105 within MA
substituted by an alanine (referred as pCS-ACHS105A) was
derived from the pCS-ACH by site-directed mutagenesis. pCS-
ACHS105A or pCS-ACH DNAs were transiently transfected into
293T cells and the virus particle release was evaluated. Forty-
eight hours after transfection, virions were recovered by
ultracentrifugation of the culture supernatant and analyzed by
immunoblotting experiments using an anti-MA anti-serum. It is
worth noting that the anti-MA anti-serum used binds both the
MA and the MAS/A proteins as shown in Fig. 5A. As shown in
Fig. 5B, virus release from cells expressing pCS-ACHS105Awas
about 30% that of cells expressing the wild type molecular
clone. No difference was observed when the corresponding cell-
associated viral proteins were analyzed (Fig. 5A). This result
indicates that MA phosphorylation in the vicinity is required for
efficient viral particles release from transfected cells.
Mutation of MA S105 phosphorylable residue results in altered
HTLV-1 budding capacity
To analyze further the contribution of MA phosphorylation
in late replicative stages, thin-section electron microscopy
experiments were performed from HTLV-1 infected HUT102
Fig. 5. Contribution of MA phosphorylation in viral release. (A) Whole cell extracts or supernatants from HTLV-1 chronically infected HUT102 cells, or HTLV-1
transfected 293T cells expressing wild type pCS-ACH (WT) or pCS-ACHS105A (S105A) were processed for Western blotting experiments using anti-MA mAbs. (B)
Band intensity was analyzed by densitometry scanning.
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pCS-ACH DNA or the pCS-ACHS105A mutant. Preparations of
chronically infected HUT102 cells (Fig. 6A) or 293T cells
expressing the pCS-ACH molecular clone allowed to detect
released particles with cone-shaped cores at the center of the
particle surrounded by an electron-lucent layer and by
membrane that are characteristic of mature virions (Fig. 6B1).Fig. 6. Contribution of S105 residue in HTLV-1 budding. HTLV-1 chronically inf
pCS-ACH (B) or pCS-ACHS105A (C) DNAs were processed for electron microscopy
of 293T cells expressing the pCS-ACHS105 molecular clone is indicated by arrows.
ACH or pCS-ACHS105A were analyzed for MA protein expression. Amounts of prIn addition, these particles displayed a diameter of 120 to
150 nm in size typical for mature extracellular HTLV-1 virions.
Interestingly, when 293T cells expressed pCS-ACH DNA,
spherical electron-dense structures reminiscent of immature
virions were also found inside the cytoplasm of the cells (Fig.
6B2). When pCS-ACHS105A DNA was transfected into 293T
cells, viral mature particles could rarely be detected at the cellected HUT102 cells (A) and transiently transfected 293T cells expressing the
as described in Materials and methods. Viral material at the plasma membrane
(D) H9 cells cocultivated with HTLV-1 transfected 293T cells expressing pCS-
oteins loaded in each lane were controlled with anti-actin mAbs.
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material were frequently observed underneath the plasma
membrane (Figs. 6C1 and C2). Most of the structures detected
were relatively flat and only slightly bulged out of the cell
surface, appearing as arrested early-assembly structures. A
number of immature viral particles at intermediate stages of
budding were also observed from these cells as shown in Fig.
6C3. Such features were infrequently detected from cells
expressing the pCS-ACH molecular clone. As a consequence,
the pattern of budding structures detected significantly differs in
cells expressing wild type HTLV-1 and HTLV-1 mutant virus
unable to phosphorylate the matrix protein at residue S105. The
infectivity of viral particles produced was next assayed in
cocultivation experiments. Forty-eight hours after transfection,
293T cells expressing the pCS-ACH molecular clone or the
pCS-ACHS105A mutant were cultured for an additional 4 days in
the presence of H9 lymphoblastoid cells. In these conditions,
wild type HTLV-1 was efficiently propagated from 293T cells to
H9 cells as evidenced by detection of MA in whole H9 cell
extract (Fig. 6D). In contrast, the presence of MA could not be
detected from extract of H9 cells cultivated in the presence of
293T cells expressing the S105 mutant, despite that MA
expression was unaffected at the cell level (Fig. 5A). As a
consequence, S105 substitution in MA protein both decreases
viral release from the host cell membrane and infectivity of viral
particles produced.
Discussion
Here we demonstrate that the HTLV-1 matrix protein is a
substrate for host-cell encoded protein kinases. One of these
kinases was identified as the cellular ERK-2 kinase that was
found to be incorporated within highly purified HTLV-1
particles. The presence of ERK-2 within HTLV-1 virions was
previously reported (Cartier et al., 1997) using particles
concentrated from the supernatant of chronically infected
C91PL cells. Our present data extend this observation using
highly purified virions prepared from supernatant of the chro-
nically infected HUT102 T-cell line. We found that ERK-2 is
incorporated within HTLV-1 particles in an activated state.
Indeed, auto-phosphorylated virus-associated ERK-2 may
account for the presence of the 42 kDa phosphorylated protein
detected after viral lysate was reacted in the presence of
radioactive ATP. This result was confirmed by BioPlex
approaches that allowed to detect phosphorylated ERK-2 from
HTLV-1 particles. Further, we showed that C-PKA and
p38MAPK protein kinases are associated to purified HTLV-1
preparations. The activation status of virus-associated PKA
remains unknown. In contrast, p38MAPK was detected from viral
lysate as a phosphorylated protein using BioPlex analysis (D.L.
unpublished data). As observed for ERK-2, the p38MAPK kinase
may thus be associated with HTLV-1 virions in an active form.
The presence of activated kinases, captured from the host cell
during budding and found associated to retroviral particles, has
been frequently reported (Cartier et al., 1997; Cartier et al.,
2003; Hui, 2002; Ott et al., 2000). In most cases, experiments
aimed at directing incorporation of inactive or inhibitor-treatedkinases into virions were found to impair viral infectivity
(Cartier et al., 2003; Jacque et al., 1998; Muller et al., 2002),
suggesting that host-cell-derived virus-associated kinases have
functional relevance during the virus replicative cycle. Inter-
estingly, PKA and ERK-2 were previously found to be
incorporated within HIV-1 and their presence within viral
particles as active forms was reported to be required for HIV-1
infectivity (Cartier et al., 1997; Cartier et al., 2003). The precise
contribution of HTLV-1 virion-associated p38MAPK and C-PKA
will remain to be investigated further.
Using site-directed mutagenesis experiments, we demon-
strated that ERK-2 contributes in viral matrix protein
phosphorylation at several sites. Among those, a conserved
MAPK consensus site located at position 105, close to the
HTLV-1 late assembly domain, was found to account for MA
phosphorylation. Substitution at this site resulted in decreased
viral particles release and altered infectivity. Despite that the
precise contribution of phosphorylation of the MA viral protein
still remains to be defined, mutation that inhibited phosphor-
ylation at position 105, close to the L-domain, was found to
result in the accumulation of viral proteins at the plasma
membrane of the host cell and decrease in virion release as
observed from electron microscopy experiments. This pheno-
type was evocative of impaired viral budding. There is
considerable evidence that demonstrate that L-domain-contain-
ing proteins are phosphorylated. For instance, the p12 protein
of Rauscher murine leukemia (Sen et al., 1977), the p12
protein of MoMLV (Yueh and Goff, 2003), p6gag from HIV-1
(Hémonnot et al., 2004; Muller et al., 2002) and pp16 from M-
PMV (Bradac and Hunter, 1984; Henderson et al., 1985) have
all been found to be phosphorylated. To date, the precise role
of L-domain-containing protein phosphorylations remains
elusive, except for the Rauscher murine leukemia virus p12
protein, the phosphorylation of which on serine residues
correlates with virion maturation (Naso et al., 1979; Yoshinaka
and Luftig, 1982) and has been proposed to modulate its RNA-
binding activity (Sen et al., 1976, 1977; Yueh and Goff, 2003).
We recently reported that p6gag L-domain-containing protein
of HIV-1 is phosphorylated. We found that viruses unable to
phosphorylate the p6gag following the substitution of a single
residue belonging to an ERK-2 consensus site display altered
budding capacities, resulting in the accumulation of virions at
the cell surface in intermediate stage of budding, a phenotype
reminiscent of L-domain defect (Hémonnot et al., 2004).
However, the precise contribution of p6gag phosphorylation
still remains undefined. It is now accepted that the late
assembly domains present on the nascent particles recruit
components of the cellular vesicle trafficking machinery to
achieve membrane fission (for review, see Demirov and Freed,
2004). Despite the fact that the particular cellular component
that interacts with the virus protein depends on the sequence of
the late domain motif, such mechanisms appear to be
conserved among budding viruses. The PTAP motif, encoded
at the C-terminal end of Gag in most retroviruses, including
SIV, HIV-1 and HIV-2, M-PMV and HTLV-1, interacts with
the ubiquitin E2 variant (UEV) protein Tsg101 Vps23
homolog, which is part of the endosomal sorting complex
437B. Hémonnot et al. / Virology 349 (2006) 430–439required for ESCRT1 transport (Martin-Serrano et al., 2003).
Connection to the class E Vps machinery through the PPXY
motif, identified as the L-domain for RSV, MLV and BLV,
occurs through the Nedd4 E3 ubiquitin ligase (Kikonyogo et
al., 2001; Strack et al., 2000; Wang et al., 2004). Finally, the
YPXL motif allows EIAV Gag protein to recruit the endocytic
sorting machinery at the level of AIP1/ALIX (Strack et al.,
2003). In any case, the ESCRT complexes have been proposed
to assemble Gag precursors that are modified by the addition
of ubiquitin at the limiting membranes of multivesicular bodies
(MVBs), causing the invagination and budding of vesicles
(Martin-Serrano et al., 2003). The contribution of phosphor-
ylations in the recruitment of cellular partners for the Gag
precursor remains unknown. Observations based on mechan-
isms regulating interactions of cellular proteins allow specu-
lating for their functional relevance. First, sequences
accounting for the retroviral L domains function are very
similar to motifs that direct phosphorylation-dependent
regulation of host cell protein–protein interactions (Strack et
al., 2003). Second, the WW domain-containing proteins
recruited through the L-domain motifs belong to a group of
modules that can bind protein ligands in a phosphorylation-
dependent manner, phosphorylation of their ligands serving as
switches in the regulation of their interactions (Lu et al., 1999;
Morris and Greenleaf, 2000; Morris et al., 1999; Verdecia et
al., 2000). Third, endocytosis and sorting of a number of
plasma membrane proteins, through pathways recruited by the
viral Gag precursor, are sequentially regulated by phosphor-
ylation and ubiquitination (Hicke, 1999). Finally, ubiquitina-
tion of Gag depending on the recruitment of host-cell ubiquitin
ligases may occur through phosphorylation-dependent
mechanisms as reported for host-cell proteins (Sudol and
Hunter, 2000). Here, we provide further evidence that the
HTLV-1 matrix protein can be phosphorylated by host-cell
kinases, supporting that phosphorylation is a feature common
to a number of retroviral L-domain-containing proteins. As
substitution of phosphorylated serine residues within HIV-1
p6gag protein (Hémonnot et al., 2004) and HTLV-1 matrix
(present study) were found to decrease viral release, L-domain
phosphorylations play a functional role that turns to be critical
before virion release. According to our observations, it is
reasonable to speculate that they may contribute in late stages
of retrovirus life cycle, probably viral budding. We are
extending our studies toward a fuller understanding of the
contribution of L-domains phosphorylations in the mechan-
isms of retroviral budding.
Materials and methods
Cell culture and transfections
Human embryonic kidney 293T cells were cultured in
Dulbecco's modified Eagle's medium (Cambrex) supplemented
with 10% fetal calf serum (Life Technologies, Inc.), 100 units/
ml penicillin, 100 μg/ml streptomycin, 2 mM glutamine. CEM,
H9 and HUT102 human T cell lines were maintained at 5 × 105
cells/ml in RPMI 1640 supplemented with 10% fetal calf serum(Life Technologies, Inc.), 100 units/ml penicillin, 100 μg/ml
streptomycin, and 2 mM glutamine. In transfection experi-
ments, cells (3 × 105) were incubated in the presence of 3 μg
viral DNA diluted in JetPei transfection reagent (QBiogen) at a
ratio of 5 units per μg of DNA. Expression of HTLV-1ACH
viruses was obtained by cotransfection of the pCS-ACH
molecular clone (Derse et al., 1995) and of the pSG-Tax vector
at a ratio of 3:1 to allow overexpression of viral proteins.
Cocultivation experiments of transfected 293T cells and H9
cells were performed at a cell ratio of 3:1 in 50% RPMI in
DMEM medium.
Virion production and purification
Purified HTLV-1 virions were prepared from chronically
infected HUT102 cell culture supernatant. Briefly, super-
natants were cleared from cellular debris by low-speed
centrifugation and filtered on 0.45 μm-pore-size membrane
(Millipore). Virions were sedimented by ultracentrifugation
through a 20% sucrose cushion, at 25,000 rpm for 2 h 30 min
at 4 °C (SW28 rotor), resuspended in 200 μl of PBS and
layered onto the top of an OptiPrep velocity gradient (6 to
20% (wt/vol) iodixanol; Abcys SA). Centrifugation was run
for 3 h at 26,000 rpm at 4 °C. Virions were recovered from
virus-containing fractions by additional ultracentrifugation at
95,000 rpm for 5 min at 4 °C (TLA100.2 rotor, Beckman
Coulter) and lysed.
In vitro phosphorylation assays
Viral lysate phosphorylation assays were carried out in the
presence of 2 μCi of [γ-32P]ATP and kinase buffer containing
50 mM HEPES (pH 7.5), 5 mM MnCl2 at 30 °C for 30 min.
When phosphorylation of GST-fused proteins was assayed,
20 ng of recombinant activated ERK-2 (Stratagene) was added
to the reaction mixture. Phosphorylated products were separated
by SDS-PAGE and detected by autoradiography.
Western blot analysis and immunoprecipitations
Proteins were separated on a 14%-ProSieve50 polyacryl-
amide gel (FMC), then transferred to PVDF membrane
(Immobilon P, Millipore) and revealed by immunoblotting
using either an anti-MA rabbit polyclonal serum (P3D11-G1-
A10, Chemicon International Inc.) or an anti-matrix monoclonal
antibody (TP-7, Abcam). Anti-ERK-2 mAbs (sc-154),
p38MAPK mAbs (sc-535) and rabbit serum raised to the
catalytic subunit of PKA (sc-903) were purchased from Santa
Cruz Biotechnology, Inc. Anti-GST mAbs were from Amer-
sham Pharmacia Biotech. Secondary antibodies conjugated to
HRP were revealed by enhanced chemiluminescent detection
(Pierce Biotechnology, Inc.). Lysate of purified HTLV-1
particles was subjected to immunoprecipitation using anti-MA
polyclonal serum. Lysate was precleared for 2 h at 4 °C in the
presence of protein-A/G plus agarose (Santa Cruz Biotechno-
logy Inc.). Cleared lysates were then incubated for 3 h with MA
specific mAbs at 4 °C. Samples were subsequently incubated
438 B. Hémonnot et al. / Virology 349 (2006) 430–439overnight at 4 °C with protein-A/G plus agarose, washed in
lysis buffer and loaded on a 10% SDS-PAGE.
BioPlex immunoassay analysis
The BioPlex (Bio-Rad Laboratories Life Sciences Group)
was used according to the instructions of the manufacturer. Our
assay is commercialized to detect activated forms of ERK-2
kinase. The bead reagent was obtained by coupling 8-μm-
diameter fluoromagnetic polystyrene beads with specific
antibodies. Unreacted sites were then blocked with 10 mM
phosphate buffer, pH 7.4, containing 150 mM sodium chloride
and 2% BSA for 2 h at room temperature. The coupling of the
antibodies on the beads was ascertained by using anti-species
antibodies conjugated to phycoerythrin. Antibody-coupled
beads (50 μl) were reacted with 50 μl of viral lysate overnight
at room temperature with gentle agitation. After three washes,
50 μl of biotinylated detection antibody was added for 30 min at
RT. After washes, beads were subsequently incubated with
50 μl of an R-phycoerythrin-conjugated streptavidin reagent
(Jackson ImmunoResearch) for 10 min at RT, washed twice,
resuspended in 125 μl of resuspension buffer and aspirated into
the Luminex detector module. The median relative fluorescent
intensity of the beads was recorded. Each test includes two
internal quality bead controls designed to monitor detector
stability, specimen and sample integrity, and the presence of
nonspecific binding that could result in inaccurate assays.
GST fusion proteins and site directed mutagenesis
GST fusion proteins containing the sequences encoding the
complete matrix, capsid and nucleocapsid were generated.
Corresponding sequences were amplified by PCR experiments
using 5′-cgtgggatccaaatcttttcccgtagc and 5′-ccgggaattctcatg-
gaaggacttgggggg; 5′-cgtgggatcccagtcatgcatccacatg and 5′-
ccgggaattctcataacactttggttttgt; and 5′-cgtgggatcgttgtccagcc-
taaaaaac and 5′-ccgggaattcttaaacctccccccctatg oligonucleotide
primer pairs respectively and cloned in frame into the pGEX-
4T1 expression vector (Amersham Pharmacia Biotech, Inc.).
GST-MA-DomL vector containing amino acids 87 to 130 of the
HTLV-1 MA protein was kindly provided by R. Z. Mamoun
(CNRS UMR5121-UM1, Montpellier) and vector encoding
GST-Elk was a gift of D. Brenner (University of North Carolina,
Chapel Hill). Vector encoding GST-MA-DomL mutant and the
pCS-ACHS105A molecular clone, where codon encoding
serine at position 105 was replaced by sequence encoding an
alanine, were obtained by site directed mutagenesis by using the
QuickChange mutagenesis kit (Stratagene) and the 5′-gccgccg-
tcagcccccacccacgacc-3′ oligonucleotide. All constructs were
confirmed by sequencing. Production and purification from
bacteria lysates were described elsewhere (Hémonnot et al.,
2004).
Electron microscopy analysis
Cells were processed for thin-section electron microscopy as
follows: cells were fixed in situ with 2.5% glutaraldehyde incacodylate buffer (pH 7.4), for 60 min at 4 °C. Cells were then
postfixed with 2% osmium tetroxide, washed in cacodylate
buffer containing 0.5% tannic acid and embedded in epon
(Embed-812, Electron Microscopy Sciences Inc.). Sections
were counterstained with uranyl acetate and lead citrate and
examined with a Hitachi H.7100 transmission electron
microscope.
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